BookRudolph M. Navari, editor.
Contents:
1. Introduction
2. The physiology and pharmacology of nausea and vomiting induced by anticancer chemotherapy in humans
3. First-generation 5-HT3 receptor antagonists
4. Palonosetron
5. The role of neurokinin-1 receptor antagonists in CINV
6. Olanzapine for the prevention of chemotherapy-induced nausea and vomiting
7. Gabapentin for the prevention of CINV
8. Prevention of CINV in patients receiving high-dose multiple-day chemotherapy
9. Clinical management of CINV
10. Treatment of chemotherapy-induced nausea
11. Conclusions
12. Future directions.